why am i not responding to semaglutide Losing Weight on Semaglutide? Why Ozempic 1 mg Isn't

Immunogenicity of BYDUREON in Pediatric Patients In a 52-week BYDUREON trial (24-week controlled and 28-week extended treatment period) for the improvement of glycemic control in pediatric patients with type 2 diabetes mellitus (Trial 9) [see Clinical Studies (14.6)], 37/58 (64%) of BYDUREON-treated patients had high titer anti-exenatide antibodies (high titer was defined as 625) at any time during the study

Patients may need help deciding whether medication is appropriate, managing side effects, protecting muscle, setting realistic goals, reviewing progress, and planning for what happens if treatment changes

In these studies, participants usually had overweight or obesity

Eur Respir J 14:98105 Jeannin P, Delneste Y, Lecoanet-Henchoz S, Gauchat JF, Life P, Holmes D, Bonnefoy JY (1995) Thiols decrease human interleukin (IL) 4 production and IL-4-induced immunoglobulin synthesis